Intravenous clot busting may be safe and effective in patients with pre-existing dependency, according to new research published in the American Heart Association journal, Stroke.
A study has shown that the treatment of medulloblastoma with proton beam therapy may be as safe as conventional photon-based radiotherapy. The treatment was shown to have similar survival rates to conventional radiotherapy in the study led by Torunn Yock, Massachusetts General Hospital, Proton Center, Boston, USA, and colleagues, published in The Lancet Oncology.
Cancer survivors of childhood brain tumours show significant deficits in intelligence, educational achievement and employment, even decades after treatment, an unprecedented study at St Jude Children´s Research Hospital has found. The researchers said their findings will help guide efforts to prevent and alleviate such problems.
According to a study conducted by the Cleveland Pre-hospital Acute Stroke Treatment (PHAST) group and published in JAMA Neurology, mobile stroke treatment units can be made more resource efficient if the need for an on-site neurologist can be eliminated by relying solely on telemedicine for physician presence.
Sequent Medical has begun enrolling patients in a study which will evaluate the safety and effectiveness of the WEB (woven endobridge) aneurysm embolisation system for the treatment of ruptured intracranial aneurysms.
Codman Neuro has launched the Enterprise 2 Vascular Reconstruction Device, the latest generation of the company’s self-expanding stent and delivery system used to treat wide-necked intracranial aneurysms and to help maintain the position of endovascular coils during and after the procedure.
The cost of altepase has more than doubled over the past ten years in the USA, whilst US Medicare/Medicaid reimbursement has lagged far behind, a presentation from the American Stroke Association’s International Stroke Conference (ISC 2016) has reported.
The identification of patients likely to benefit from stroke clot removal may be made more accurate with the use of brain imaging, rather than relying on the amount of time since symptoms began, according to research presented at the American Stroke Association’s International Stroke Conference (ISC 2016).
Higher pollution levels have been associated with a higher total number of strokes, according to research presented at the American Stroke Association’s International Stroke Conference (ISC 2016).
The rapid improvement of symptoms before arrival at hospital does not always lead to better recovery for stroke patients, according to new research presented at the American Stroke Association International Stroke Conference (ISC 2016).
A clinical trial has found no significant differences between the use of carotid-artery stenting and carotid endarterectomy over a period of five years for the prevention of strokes in asymptomatic patients with serious narrowing of the carotid artery.
Mercy Life Flight Network and Samsung Neurologica have announced the debut of a mobile stroke unit (MSU) serving Northwestern Ohio, USA residents. This is the fourth unit of its kind in the USA.
Long-term follow-up results of the CREST trial show no significant difference between patients who underwent stenting and those who underwent endarterectomy with respect to the risk of periprocedural stroke, myocardial infarction, or death and subsequent ipsilateral stroke at 10 years. The rate of postprocedural ipsilateral stroke also did not differ between groups.
Medtronic is to launch the OsteoCool radiofrequency ablation system for surgeons who treat patients with painful spinal metastases. The system has been granted US Food and Drug Administration (FDA) 510(k) marketing clearance.
At the 2015 annual meeting of the European Society of Minimally Invasive Neurological Therapy (ESMINT; 10–12 September, Nice, France) Gyula Gal (Department of Radiology, University Hospital Odense, Denmark) reported his experience with the PulseRider aneurysm neck reconstruction device (Pulsar Vascular/Codman Neuro).
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos